Enantiomeric profiling of chiral drugs in wastewater and receiving waters

Environmental Science and Technology

Volumn 46, Issue 3, 2012, Pages 1681-1691

  Kasprzyk Hordern, Barbara ^a   Baker, David R ^b  

^a University of Bath Claverton Down   (United Kingdom)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED SLUDGE; AQUEOUS ENVIRONMENT; ATENOLOL; CHIRAL DRUGS; DRUGS OF ABUSE; MONITORING PROGRAMS; PSEUDOEPHEDRINE; RECEIVING WATERS; SAMPLING POINTS; TREATMENT TECHNOLOGIES; TRICKLING FILTER; VENLAFAXINE;

CHIRALITY; DRUG PRODUCTS; FILTERS (FOR FLUIDS); STEREOSELECTIVITY;

ENANTIOMERS;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ATENOLOL; CHIRAL DRUG; DRUG; EPHEDRINE; METHAMPHETAMINE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG; VENLAFAXINE; WATER;

ACTIVATED SLUDGE; AQUEOUS SOLUTION; BIOREACTOR; DRUG; SAMPLING; WASTE TREATMENT; WASTEWATER;

ACTIVATED SLUDGE; ARTICLE; CHIRALITY; ENANTIOMER; ENVIRONMENTAL MONITORING; SPRING; STEREOCHEMISTRY; SUMMER; TRICKLING FILTER; WASTE WATER TREATMENT PLANT;

AMPHETAMINES; ATENOLOL; CHROMATOGRAPHY, LIQUID; CYCLOHEXANOLS; EPHEDRINE; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; STREET DRUGS; TANDEM MASS SPECTROMETRY; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84856755934     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es203113y     Document Type: Article

References (33)

1. Illicit Drugs in the Environment; Castiglioni, S., Zuccato, E., Fanelli, R., Eds.; Wiley: New York, 2011.
2. Kasprzyk-Hordern, B. Pharmacologically active compounds in the environment and their chirality Chem. Soc. Rev. 2010, 39, 4466-4503
3. Kasprzyk-Hordern, B.; Kondakal, K.; Baker, D. R. Enantiomeric profiling of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry J. Chromatogr., A 2010, 1217, 4575-4586
4. Fono, L. J.; Sedlak, D. L. Use of chiral pharmaceutical propranolol to identify sewage discharges into surface waters Environ. Sci. Technol. 2005, 39, 9244-9252 (Pubitemid 41741212)
5. Fono, L. J.; Kolodziej, E. P.; Sedlak, D. L. Attenuation of wastewater-derived contaminants in the effluent-dominated river Environ. Sci. Technol. 2006, 40, 7257-7262 (Pubitemid 44871835)
6. Buser, H.-R.; Poiger, T.; Müller, D. Occurrence and environnemental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and wastewaters Environ. Sci. Technol. 1999, 33, 2529-2535 (Pubitemid 29379047)
7. Nikolai, L. N.; McClure, L.; MacLeod, S. L.; Wong, C. S. Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry J. Chromatogr., A 2006, 1131, 103-109 (Pubitemid 44485666)
8. MacLeod, S. L.; Sudhir, P.; Wong, C. S. Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry J. Chromatogr., A 2007, 1170, 23-33 (Pubitemid 47539466)
9. Matamoros, V.; Hijosa, M.; Bayona, J. M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibupforen and naproxen Chemosphere 2009, 75, 200-205
10. Winkler, M.; Lawrence, J. R.; Neu, T. R. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems Water Res. 2001, 35, 3197-3205 (Pubitemid 32664124)
11. Stanley, J. K.; Ramirez, A. J.; Chambliss, C. K.; Brooks, B. W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate Chemosphere 2007, 69, 9-16 (Pubitemid 47187491)
12. Stanley, J. K.; Ramirez, A. J.; Mottaleb, M.; Chambliss, C. K.; Brooks, B. W. Enantiospecific toxicity of the β-blocker propranolol to Daphnia Magna and Pimephales Promelas Environ. Toxicol. Chem. 2006, 25, 1780-1786 (Pubitemid 44669848)
13. Baker, D. R.; Kasprzyk-Hordern, B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionization tandem mass spectrometry J. Chromatogr., A 2011, 1218, 1620-1631
14. Buechler, J.; Schwab, M.; Mikus, G.; Fischer, B.; Hermle, L.; Marx, C.; Grön, G; Spitzer, M.; Kovar, K.-A. Enantioselective quantitation of the ecstasy compound (R)- and (S)- N -ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma and urine J. Chromatogr., B 2003, 793, 207-222 (Pubitemid 37271961)
15. Fornstedt, T.; Hesselgren, A.-M.; Johansson, M. Chiral assay of atenolol present in microdialysis and plasma samples of rats using chiral CBH as stationary phase Chirality 1997, 329-333
16. Isaksson, R.; Pettersson, C.; Pettersson, G.; Jönsson, S.; Stålberg, J.; Hermansson, J.; Marle, I. Cellulases as chiral selectors Trends Anal. Chem. 1994, 13, 431-439 (Pubitemid 124003188)
17. Fantegrossi, W. E. In vivo pharmacology of MDMA and its enantiomers in Rhesus monkeys Exp. Clin. Psychopharmacol. 2008, 16, 1-12 (Pubitemid 351305490)
18. Moore, K. A.; Mozayani, A.; Fierroc, M. F.; Poklis, A. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4 methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning Forensic Sci. Int. 1996, 83, 111-119 (Pubitemid 27007232)
19. Levine, B. Principles of Forensic Toxicology; AACC Press: Washington, DC, 2003.
20. King, L. A. Forensic Chemistry of Substance Misuse; RSC Publishing: London, 2009.
21. Meyer, M. R.; Peters, F. T.; Maurer, H. H. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers Toxicol. Lett. 2009, 190, 54-60
22. Cody, J. T. Precursors medications as a source of methamphetamine and/or amphetamine positive drug testing results J. Occup. Environ. Med. 2002, 44, 435-450 (Pubitemid 34516356)
23. Prescription Cost Analysis, England, National Health Service, 2010 (http://www.ic.nhs.uk/pubs/prescostanalysis2010; accessed January 2011).
24. Cody, J. T.; Schwarzhoft, R. Interpretation of methamphetamine and amphetamine enantiomer data J. Anal. Toxicol. 1993, 17, 321-326 (Pubitemid 23286731)
25. McCooeye, M.; Ding, L.; Gardner, G. J.; Fraser, C. A.; Lam, J.; Sturgeon, R. E.; Mester, Z. Separation and quantitation of the stereoisomers of ephedra alkaloids in natural health products using flow injection-electrospray ionization-high filed asymmetric waveform ion mobility spectrometry-mass spectrometry Anal. Chem. 2003, 75, 2538-2542 (Pubitemid 36667096)
26. Chiaia, A. C.; Banta-Green, C.; Field, J. Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in US wastewaters Environ. Sci. Technol. 2008, 42, 8841-8848
27. Postigo, Ch.; Lopez de Alda, M. J.; Barceló, D. Fully automated determination in the low nanogram per liter level of different classes of drugs of abuse in sewage water by on-line solid-phase extraction-liquid solid-phase extraction-liquid chromatography-electrospray-tandem mass spectrometry Anal. Chem. 2008, 80, 3123-3134 (Pubitemid 351620696)
28. Kingbäck, M.; Josefsson, M.; Karlsson, L.; Ahlner, J.; Bengtsson, F.; Kugelberg, F. C.; Carlsson, B. Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction J. Pharm. Biomed. Anal. 2010, 53, 583-590
29. Eap, Ch. B.; Lessard, E.; Baumann, P.; Brawand-Amey, M.; Yessine, M.-A.; O'Hara, G.; Turgeon, J. Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans Pharmacogenetics 2003, 13, 39-47 (Pubitemid 36135685)
30. Mehvar, R.; Brooks, D. R. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans J. Pharm. Pharm. Sci. 2001, 4, 185-200 (Pubitemid 34305610)
31. MacLeod, S. L.; Wong, Ch. S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments Water Res. 2010, 44, 533-544
32. Measuring Different Aspects of Problem Drug Use: Methodological Developments. Home Office Online Report 16/06; Singleton, N.; Murray, R.; Tinsley, L., Eds.; 2006; www.homeoffice.gov.uk/rds/pdfs06/rdsolr1606.pdf.
33. Baker, D. R.; Kasprzyk-Hordern, B. Critical evaluation of methodology commonly used in sample collection, storage and preparation in the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by SPE-LC/MS J. Chromatogr., A 2011, 1218 (44) 8036-8059